HUP0300125A3 - Anaesthetic formulations containing propofol - Google Patents

Anaesthetic formulations containing propofol

Info

Publication number
HUP0300125A3
HUP0300125A3 HU0300125A HUP0300125A HUP0300125A3 HU P0300125 A3 HUP0300125 A3 HU P0300125A3 HU 0300125 A HU0300125 A HU 0300125A HU P0300125 A HUP0300125 A HU P0300125A HU P0300125 A3 HUP0300125 A3 HU P0300125A3
Authority
HU
Hungary
Prior art keywords
formulations containing
containing propofol
anaesthetic formulations
anaesthetic
propofol
Prior art date
Application number
HU0300125A
Other languages
English (en)
Original Assignee
Maelor Pharmaceuticals Ltd Wre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Pharmaceuticals Ltd Wre filed Critical Maelor Pharmaceuticals Ltd Wre
Publication of HUP0300125A2 publication Critical patent/HUP0300125A2/hu
Publication of HUP0300125A3 publication Critical patent/HUP0300125A3/hu
Publication of HU226485B1 publication Critical patent/HU226485B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300125A 2000-02-29 2001-02-28 Anaesthetic formulations containing propofol HU226485B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0004841A GB2359747B (en) 2000-02-29 2000-02-29 Anaesthetic formulations
PCT/GB2001/000868 WO2001064187A2 (en) 2000-02-29 2001-02-28 Anaesthetic formulations

Publications (3)

Publication Number Publication Date
HUP0300125A2 HUP0300125A2 (hu) 2003-07-28
HUP0300125A3 true HUP0300125A3 (en) 2003-09-29
HU226485B1 HU226485B1 (en) 2009-03-02

Family

ID=9886669

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300125A HU226485B1 (en) 2000-02-29 2001-02-28 Anaesthetic formulations containing propofol

Country Status (21)

Country Link
US (2) US7166303B2 (hu)
EP (1) EP1259226B1 (hu)
JP (1) JP4215430B2 (hu)
KR (1) KR100652552B1 (hu)
CN (1) CN100376232C (hu)
AT (1) ATE324101T1 (hu)
AU (2) AU3580901A (hu)
BR (1) BR0108738A (hu)
CA (1) CA2401089C (hu)
CZ (1) CZ300790B6 (hu)
DE (1) DE60119082T2 (hu)
DK (1) DK1259226T3 (hu)
ES (1) ES2262628T3 (hu)
GB (1) GB2359747B (hu)
HU (1) HU226485B1 (hu)
IL (2) IL151311A0 (hu)
NO (1) NO20024095L (hu)
NZ (1) NZ520765A (hu)
RU (1) RU2250101C2 (hu)
WO (1) WO2001064187A2 (hu)
ZA (1) ZA200206233B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
GB0120701D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
EP1492544A4 (en) * 2002-04-08 2005-10-12 Guilford Pharm Inc PHARMACEUTICAL COMPOSITIONS CONTAINING PROPOFOL-BASED WATER-SOLUBLE PRODRUGS AND METHODS OF ADMINISTRATION THEREOF
NZ538255A (en) 2002-07-29 2006-11-30 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
GB0327390D0 (en) * 2003-11-25 2003-12-31 Pfizer Ltd Pharmaceutical formulations
AU2005215517C1 (en) * 2004-02-13 2011-04-14 Bioavailability, Inc. A microemulsion preparation of high concentration propofol for anesthetic uses
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
DE602005011500D1 (de) * 2005-07-08 2009-01-15 Physica Pharma Klare pharmazeutische wässrige mikroemulsion mit propofol und herstellungsverfahren
WO2007108505A1 (ja) * 2006-03-22 2007-09-27 Chugai Seiyaku Kabushiki Kaisha エリスロポエチン溶液製剤
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
JP2010504318A (ja) * 2006-09-22 2010-02-12 ラボファーム インコーポレイテッド ｐＨ標的化薬剤送達のための組成物及び方法
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
WO2010088924A1 (en) * 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
WO2012151544A1 (en) * 2011-05-05 2012-11-08 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
JP6235755B2 (ja) 2014-07-02 2017-11-22 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク 高いカーゴ対サーファクタント比を有するサーファクタント除去ミセル組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
DE69912441T2 (de) * 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations

Also Published As

Publication number Publication date
CN1416337A (zh) 2003-05-07
BR0108738A (pt) 2002-12-17
US20030138489A1 (en) 2003-07-24
RU2250101C2 (ru) 2005-04-20
HU226485B1 (en) 2009-03-02
GB2359747A (en) 2001-09-05
KR100652552B1 (ko) 2006-11-30
NZ520765A (en) 2003-07-25
WO2001064187B1 (en) 2002-03-07
IL151311A (en) 2007-10-31
US20070122467A1 (en) 2007-05-31
JP2003525231A (ja) 2003-08-26
HUP0300125A2 (hu) 2003-07-28
CA2401089A1 (en) 2001-09-07
DK1259226T3 (da) 2006-08-21
ES2262628T3 (es) 2006-12-01
GB2359747B (en) 2002-04-24
GB0004841D0 (en) 2000-04-19
DE60119082D1 (de) 2006-06-01
IL151311A0 (en) 2003-04-10
JP4215430B2 (ja) 2009-01-28
CN100376232C (zh) 2008-03-26
ZA200206233B (en) 2003-11-05
AU3580901A (en) 2001-09-12
CZ300790B6 (cs) 2009-08-12
RU2002123180A (ru) 2004-03-20
WO2001064187A3 (en) 2002-01-03
ATE324101T1 (de) 2006-05-15
CZ20022914A3 (cs) 2003-01-15
US7166303B2 (en) 2007-01-23
EP1259226A2 (en) 2002-11-27
EP1259226B1 (en) 2006-04-26
CA2401089C (en) 2011-01-18
NO20024095L (no) 2002-10-23
WO2001064187A8 (en) 2002-10-03
KR20030011781A (ko) 2003-02-11
NO20024095D0 (no) 2002-08-28
AU2001235809B2 (en) 2004-08-05
WO2001064187A2 (en) 2001-09-07
DE60119082T2 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
HUP0300125A3 (en) Anaesthetic formulations containing propofol
GB0009583D0 (en) Respiratory formulations
EP1263461A4 (en) ADENOVIRUS FORMULATIONS
EP1226807A4 (en) CUREABLE DENTAL COMPOSITION
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
HUP0300768A3 (en) Pesticidal formulations
GB0020089D0 (en) Vaccine Composition
AU1131102A (en) Medicinal aerosol formulations
AU6383901A (en) Liquid formulations
GB0019232D0 (en) Antiperspirant formulations
IL153907A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 2-METHYLENE-19-NOR-20(S)-1alpha, 25-DIHYDROXYVITAMIN D3
EP1329224A4 (en) PREPARATIONS OF STABILIZED SOLUTIONS OVER A LONG PERIOD OF TIME
HK1057474A1 (en) Medicinal composition
GB0015490D0 (en) Novel formulations
GB0011807D0 (en) Formulation for inhalation
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
AU9409101A (en) Mesotrione formulations
GB0019230D0 (en) Antiperspirant formulations
PT1279679E (pt) Composição contendo leishmânia lip2a
GB0009607D0 (en) Medical compositions
AU9482601A (en) Tocol-based compositions containing amiodarone
AU8254101A (en) Medicinal compositions
GB0115893D0 (en) Formulations
GB0022027D0 (en) Disfectant formulations

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees